Six pathogens that are resistant to antibiotics lead to national health care costs exceeding $4.6 billion each year, according to a report released Thursday by the U.S. Centers for Disease Control and Prevention and the University of Utah.
The Infectious Diseases Society of America seeks candidates to serve in the position of editor-in-chief of The Journal of Infectious Diseases. The current editor-in-chief, Martin S. Hirsch, MD, FIDSA, is stepping down at the end of 2022 after a distinguished term of service.
Declining rates of coronavirus infections, illnesses and deaths across the country reflect the success of public health measures we’ve taken and the benefits of increasing access to effective vaccines against the virus. Reports indicating that these reductions have stalled should remind us that our progress is fragile.
The Biden Administration’s American Rescue Plan passed by the House Saturday reflects priorities important to the Infectious Diseases Society of America and its HIV Medicine Association, and is responsive to recommendations and concerns voiced by us
The emergency use authorization of a third vaccine against COVID-19 in the United States today, just over a year since the virus was identified, demonstrates extraordinary scientific commitment and progress.
New CDC findings further confirm that wearing a well-fitting mask can significantly reduce the risk of coronavirus infection. CDC offers tips for improving mask fit; for some individuals, double-masking may be helpful to improve fit, but it is not necessary for all.
As the U.S. health care system grapples with unrelenting increases in COVID-19 cases during a pandemic that has claimed the lives of more than 400,000 Americans, IDSA and the CDC have extended their partnership to equip frontline health care professionals with the latest information on fighting the disease.
Antibiotic resistance could be the next epidemic to highlight the impacts of structural racism on health and access to health services, caution the authors of an analysis published in Nature Medicine Monday. The article argues that stronger measures to combat antibiotic resistance should be a key component of broader efforts to promote health equity.
President Biden’s executive orders and national strategy to contain the COVID-19 pandemic, along with renewed participation in the World Health Organization, offer a comprehensive approach with tremendous promise toward ending the nation’s public health crisis.
The Infectious Diseases Society of America and its HIV Medicine Association strongly endorse the executive order signed by President Biden today requiring face masks on federal property and other areas of federal authority for the next 100 days to prevent the spread of COVID-19.
The Infectious Diseases Society of America and its HIV Medicine Association strongly support the incoming Administration’s request for $400 billion to strengthen our pandemic response and safely reopen schools.
Plans to significantly accelerate COVID-19 vaccine rollout announced by the Department of Health and Human Services today represent an important step toward controlling the pandemic.